27.05.2014 • NewsanilineBASFDede Willams

BASF-Huntsman Chinese MDI Plant Gets OK to Double Output

Lianheng Isocyanate, the joint venture of BASF and Huntsman and Chinese partners has received permission to double its MDI capacity in the Shanghai Chemical Industry Park (SCIP) to 480,000 t/y from the current 240,000 t/y.

The new capacity at the $1 billion complex, which went on stream in mid-2008, is due to be in place by 2016. The plant also produces MDI precursors aniline and nitrobenzene.

BASF and Huntsman each own 35% of the Lianheng Isocayanate, with the remainder in the hands of Shanghai Hua Yi, Sinopec Shanghai Gao Qiao Petrochemical Corporation and Shanghai Chlor-Alkali Chemical Co.

The SCIP complex also houses two other joint ventures.

Shanghai BASF Polyurethane Co, a partnership of BASF, Shanghai Hua Yi and Sinopec Shanghai Gao Qiao Petrochemical Corporation, operates an MDI finishing plant and a 160,000 t/y production facility for TDI and its precursors nitric acid and dinitrobenzene at the site.

Huntsman Polyurethane Shanghai, a joint venture between the US company and Shanghai Chlor-Alkali Chemical. operates an MDI finishing plant and a plant for prepolymers.

At BASF's Investors Day in London on May 22, board member Wayne Smith said the German group's wholly owned 400,000 t/y MDI plant at Chongqing in western China, will now go on stream in the second quarter of 2015, rather than in 2014 as planned. Smith said the delay is related to the Chinese government's decision to increase the price of gas paid by chemical producers.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.